Rss Feed

Subscribe to Rss Feed feed
Latest Medical Research News and Research
Updated: 35 min 47 sec ago

Scientists reveal how cholera bacteria activate toxin genes in the human gut

Wed, 01/14/2026 - 23:34
Cholera remains a major global public health challenge, with an estimated 1.3 to 4 million cases and tens of thousands of deaths reported worldwide each year.

Six week casting proves as effective as surgery for unstable ankle fractures

Wed, 01/14/2026 - 23:26
Wearing a cast for six weeks appears to be no less effective than surgery for healing unstable ankle fractures and carries fewer treatment related harms, finds a clinical trial from Finland published by The BMJ today.

Gut bacteria compound during pregnancy protects offspring from fatty liver disease

Wed, 01/14/2026 - 23:17
Children born to mothers who consume a high-fat, high-sugar diet during pregnancy and breastfeeding face a higher risk of developing fatty liver disease later in life.

Bacterial metabolite enhances immune checkpoint therapy against lung cancer

Wed, 01/14/2026 - 23:03
UF Health Cancer Institute researchers have discovered a small compound produced naturally by gut bacteria that doubled the response to lung cancer immunotherapy treatment in mice and can now be made into a drug for testing in humans.

Scientists uncover promising therapeutic target for autoimmune disease affecting the brain

Wed, 01/14/2026 - 21:41
Scientists have identified a promising target for treatment of a devasting autoimmune disease affecting the brain.

Pregnant individuals with inflammatory bowel disease show heightened vaginal inflammation

Wed, 01/14/2026 - 21:37
Pregnant individuals with inflammatory bowel disease (IBD) have higher levels of pro-inflammatory immune molecules, known as cytokines, in their vaginal mucosa than their healthy counterparts, according to a new study published January 14, 2026 in the open-access journal PLOS One by Ana Maldonado-Contreras of University of Massachusetts Chan Medical School, U.S., and colleagues.

Study reveals genetic signatures linked to HIV-related cognitive impairment

Wed, 01/14/2026 - 21:34
Using participant skin cells reprogrammed into neurons, Weill Cornell Medicine researchers have identified genetic signatures associated with HIV infection that may contribute to the cognitive impairment that often occurs in people living with HIV, even when the virus is controlled.

Rare immune events link Epstein Barr virus to early multiple sclerosis damage

Wed, 01/14/2026 - 21:29
Autoimmune diseases such as multiple sclerosis arise when the immune system turns against the body itself.

Bradycardia emerges as key clinical sign of xylazine-opioid overdose

Wed, 01/14/2026 - 21:26
Researchers have identified bradycardia-an abnormally low heart rate–as a symptom of xylazine-opioid overdose.

Age-tailored therapies needed for treating the young and old with sepsis

Wed, 01/14/2026 - 14:01
Dealing with an infection isn't as straightforward as simply killing the pathogen. The body also needs to carefully steer and monitor its immune response to prevent collateral damage.

Heart failure care gaps found among Asian American ethnic groups

Wed, 01/14/2026 - 13:19
Using nearly a decade of data (2015–2023) from 800+ U.S. hospitals and more than 700,000 patients overall, Northwestern researchers found that when Asian American heart failure patients are separated by ethnicity, rather than grouped together as "Asian," important differences in care emerge across groups including Filipino, Vietnamese, Chinese, Asian Indian, Korean and Japanese patients.

HIF1 protein identified as key driver of tendon pain

Wed, 01/14/2026 - 13:10
Overuse of our tendons can cause painful medical conditions for which only limited treatment options exist. Researchers have now deciphered an important molecular mechanism that triggers these problems.

Post-meal blood sugar spikes linked to increased Alzheimer's risk

Wed, 01/14/2026 - 12:47
A new study led by researchers from the University of Liverpool has found that spikes in blood sugar after meals may increase the risk of Alzheimer's disease.

Disease-responsive nanoparticles enable ghrelin mRNA therapy in osteoarthritis

Wed, 01/14/2026 - 12:25
Nitin Joshi, PhD, and Jingjing Gao, PhD, of the Department of Anesthesiology at Mass General Brigham, are the co-senior authors of a paper published in Nature Nanotechnology, "A disease-severity-responsive nanoparticle enables potent ghrelin mRNA therapy in osteoarthritis." Mahima Dewani, PhD, is the lead author of this study.

WSU study reveals gaps in end-of-life care education for doctors

Wed, 01/14/2026 - 12:09
Doctors encounter death and dying significantly more than most people. It's the price of saving lives and helping people.

RAS-MAPK inhibition halts spinal deformity in neurofibromatosis type 1 mouse model

Wed, 01/14/2026 - 12:03
Spinal deformities such as scoliosis and kyphosis are among the most serious complications of neurofibromatosis type 1 (NF1), a genetic disorder that affects about one in 3,000 people.

Bacterial toxin shrinks tumors, enhances immune response in colorectal cancer study

Wed, 01/14/2026 - 11:58
A toxin secreted by cholera bacteria can inhibit the growth of colorectal cancer without causing any measurable damage to the body. This is shown by a new study by researchers at Umeå University, Sweden.

PFAS exposure linked to gestational diabetes and insulin problems

Wed, 01/14/2026 - 11:51
Exposure to per- and polyfluoroalkyl substances (PFAS), a class of highly persistent environmental chemicals commonly referred to as "forever chemicals," is associated with a higher risk of gestational diabetes mellitus and altered markers of insulin resistance and insulin secretion, according to a new systematic review and meta-analysis led by researchers at the Icahn School of Medicine at Mount Sinai.

DLL3 on circulating tumor cells predicts tarlatamab success in lung cancer

Wed, 01/14/2026 - 11:27
A team led by investigators at the Mass General Brigham Cancer Institute has discovered that a particular marker on tumor cells circulating in the blood indicates whether a patient with lung cancer will experience a lasting response to a newly approved immunotherapy called tarlatamab.

Endocrine-disrupting chemicals and adverse life events during pregnancy affect children's development

Wed, 01/14/2026 - 11:07
Research at Karlstad University shows that exposure to endocrine-disrupting chemicals and adverse life events during pregnancy can influence children's behavior and brain development.

Pages